Biotechnology
12 articles
Organ-on-a-Chip: How Microfluidic Human Tissue Models Are Rewriting Drug Testing
Organ-on-a-chip technology uses microfluidic devices to create miniature, functional models of human organs from living cells, offering a more physiologically relevant alternative to traditional drug testing methods that suffer from high failure rates in humans.
Longevity Science's Ethical Divide: Will Only the Rich Live Forever?
Experts warn that extended lifespans could lead to "longevity without security," forcing additional decades of work and financial strain on those without corresponding societal reforms, according to t
What Is Personalized Medicine's Microbiome Influence on Health?
In a healthy human adult, bacterial cells outnumber human cells by approximately ten to one, and their collective genes exceed our own by a factor of 200, according to the NIH Common Fund and Baylor C
How Are Organoids Made and What's Their Impact on Medicine?
In 2017, scientists successfully grew miniature liver cancers in a laboratory dish.
CRISPR yields climate-resilient crops, boosting food security
In 2021, Japan quietly introduced the world's first CRISPR-edited tomato, the Sicilian Rouge High GABA, engineered not just for resilience but enhanced nutritional content.
What is CRISPR Gene Editing and Why is it Revolutionizing Medicine?
In February 2025, KJ Muldoon became the first person to receive a personalized CRISPR therapy for a life-threatening metabolic disorder, according to Nature .
Stripe, Anthropic, OpenAI Launch $500M Fund to Fight Respiratory Infections
Stripe, Anthropic, and OpenAI lead a coalition of backers, including Flu Lab, the OpenAI Foundation, Bill Gates, and Jane Street Capital traders, in Intercept: a new $500 million fund aiming to elimin
Cellular reprogramming reverses aging markers in lab
Scientists recently reversed cellular aging markers in human skin cells by 30 years in a lab dish.
AI Accelerates Whole Body Rejuvenation Drug Discovery for Healthspan
David Sinclair plans to launch human tests of an oral 'reprogramming' drug as part of a $101 million XPrize competition, according to MIT Technology Review .
David Sinclair's Company Gets FDA Nod for Rejuvenation Trial
Life Biosciences, co-founded by prominent longevity researcher David Sinclair, has received FDA approval to begin the first human trial for a 'rejuvenation treatment' called ER-100.
How CRISPR-Cas9 Gene Editing Works: Target, Cut, Repair
CRISPR-Cas9 gene editing works by using a guide RNA to target a specific DNA sequence, a Cas9 enzyme to cut it, and the cell's natural repair mechanisms to alter the gene. This revolutionary technology is being applied to treat genetic diseases and improve crops, but faces challenges in delivery, precision, and ethical considerations, particularly regarding heritable germline edits.
Ebola outbreak control challenges mount with Bundibugyo species spread
The current Ebola outbreak in the Democratic Republic of the Congo and Uganda silently spread for weeks before a nurse, the first known case, developed symptoms on April 24, according to BBC .